vs
Monte Rosa Therapeutics, Inc.（GLUE）与Rent the Runway, Inc.（RENT）财务数据对比。点击上方公司名可切换其他公司
Monte Rosa Therapeutics, Inc.的季度营收约是Rent the Runway, Inc.的1.2倍（$12.8M vs $10.6M），Rent the Runway, Inc.净利率更高（721.7% vs -212.1%，领先933.8%），Monte Rosa Therapeutics, Inc.同比增速更快（38.5% vs 10.4%）
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
Rent the Runway Inc.是总部位于纽约的美国电商平台，由珍妮弗·海曼与珍妮弗·弗莱斯于2009年11月创立，主打设计师品牌服饰与配饰的租赁、订阅以及购买服务，是设计师服饰共享租赁模式的开创平台之一。
GLUE vs RENT — 直观对比
营收规模更大
GLUE
是对方的1.2倍
$10.6M
营收增速更快
GLUE
高出28.1%
10.4%
净利率更高
RENT
高出933.8%
-212.1%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $12.8M | $10.6M |
| 净利润 | $-27.1M | $76.5M |
| 毛利率 | — | -126.4% |
| 营业利润率 | -258.3% | -152.8% |
| 净利率 | -212.1% | 721.7% |
| 营收同比 | 38.5% | 10.4% |
| 净利润同比 | -13.5% | 504.8% |
| 每股收益（稀释后） | — | $13.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLUERENT
| Q4 25 | — | $10.6M | ||
| Q3 25 | $12.8M | $11.7M | ||
| Q2 25 | $23.2M | $7.6M | ||
| Q1 25 | $84.9M | $11.8M | ||
| Q4 24 | $60.6M | $9.6M | ||
| Q3 24 | — | $10.4M | ||
| Q2 24 | — | $8.9M | ||
| Q1 24 | — | $10.4M |
净利润GLUERENT
| Q4 25 | — | $76.5M | ||
| Q3 25 | $-27.1M | $-26.4M | ||
| Q2 25 | $-12.3M | $-26.1M | ||
| Q1 25 | $46.9M | $-13.4M | ||
| Q4 24 | $13.4M | $-18.9M | ||
| Q3 24 | — | $-15.6M | ||
| Q2 24 | — | $-22.0M | ||
| Q1 24 | — | $-24.8M |
毛利率GLUERENT
| Q4 25 | — | -126.4% | ||
| Q3 25 | — | -92.3% | ||
| Q2 25 | — | -168.4% | ||
| Q1 25 | — | -71.2% | ||
| Q4 24 | — | -122.9% | ||
| Q3 24 | — | -98.1% | ||
| Q2 24 | — | -131.5% | ||
| Q1 24 | — | -93.3% |
营业利润率GLUERENT
| Q4 25 | — | -152.8% | ||
| Q3 25 | -258.3% | -171.8% | ||
| Q2 25 | -67.1% | -259.2% | ||
| Q1 25 | 51.9% | -65.3% | ||
| Q4 24 | 21.4% | -142.7% | ||
| Q3 24 | — | -92.3% | ||
| Q2 24 | — | -185.4% | ||
| Q1 24 | — | -185.6% |
净利率GLUERENT
| Q4 25 | — | 721.7% | ||
| Q3 25 | -212.1% | -225.6% | ||
| Q2 25 | -53.0% | -343.4% | ||
| Q1 25 | 55.2% | -113.6% | ||
| Q4 24 | 22.2% | -196.9% | ||
| Q3 24 | — | -150.0% | ||
| Q2 24 | — | -247.2% | ||
| Q1 24 | — | -238.5% |
每股收益（稀释后）GLUERENT
| Q4 25 | — | $13.65 | ||
| Q3 25 | — | $-6.55 | ||
| Q2 25 | — | $-6.58 | ||
| Q1 25 | — | $-2.72 | ||
| Q4 24 | — | $-4.70 | ||
| Q3 24 | — | $-4.17 | ||
| Q2 24 | — | $-6.03 | ||
| Q1 24 | — | $-5.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.3M | $50.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.8M | $-35.1M |
| 总资产 | $459.8M | $231.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLUERENT
| Q4 25 | — | $50.7M | ||
| Q3 25 | $208.3M | $43.6M | ||
| Q2 25 | $69.4M | $70.4M | ||
| Q1 25 | $78.5M | $77.4M | ||
| Q4 24 | $224.3M | $74.1M | ||
| Q3 24 | — | $76.6M | ||
| Q2 24 | — | $82.0M | ||
| Q1 24 | — | $84.0M |
总债务GLUERENT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $340.6M | ||
| Q1 25 | — | $333.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GLUERENT
| Q4 25 | — | $-35.1M | ||
| Q3 25 | $245.8M | $-232.1M | ||
| Q2 25 | $268.1M | $-207.1M | ||
| Q1 25 | $275.2M | $-182.5M | ||
| Q4 24 | $222.9M | $-171.2M | ||
| Q3 24 | — | $-154.5M | ||
| Q2 24 | — | $-141.3M | ||
| Q1 24 | — | $-122.3M |
总资产GLUERENT
| Q4 25 | — | $231.0M | ||
| Q3 25 | $459.8M | $219.0M | ||
| Q2 25 | $359.6M | $245.3M | ||
| Q1 25 | $393.2M | $240.0M | ||
| Q4 24 | $438.7M | $251.6M | ||
| Q3 24 | — | $257.4M | ||
| Q2 24 | — | $278.4M | ||
| Q1 24 | — | $278.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.4M | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | $99.8M | — |
| 自由现金流率自由现金流/营收 | 781.5% | — |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $145.0M | — |
8季度趋势，按日历期对齐
经营现金流GLUERENT
| Q4 25 | — | $-1.4M | ||
| Q3 25 | $100.4M | $-10.5M | ||
| Q2 25 | $-34.7M | $8.3M | ||
| Q1 25 | $-45.5M | $1.4M | ||
| Q4 24 | $128.9M | $4.7M | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | $-8.0M |
自由现金流GLUERENT
| Q4 25 | — | — | ||
| Q3 25 | $99.8M | — | ||
| Q2 25 | $-36.4M | — | ||
| Q1 25 | $-47.1M | — | ||
| Q4 24 | $128.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率GLUERENT
| Q4 25 | — | — | ||
| Q3 25 | 781.5% | — | ||
| Q2 25 | -157.0% | — | ||
| Q1 25 | -55.4% | — | ||
| Q4 24 | 212.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度GLUERENT
| Q4 25 | — | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率GLUERENT
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.97× | — | ||
| Q4 24 | 9.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
